El antagonista periférico alfa-2 vatinoxano mejora el flujo de líquido cefalorraquídeo perivascular inducido por

Hanna Antila1, Sonja C Jalonen2, Niklas Daniel Åke Persson2

  • 1Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Neuroscience Center, HiLIFE, University of Helsinki, Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Neuropharmacology
|January 4, 2026
PubMed
Resumen

No abstract available in PubMed .